The Role of Sirtuins in Improving Cardiovascular Function and the Prevention of Aging
Access to this document is restricted. Some items have been embargoed at the request of the author, but will be made publicly available after the "No Access Until" date.
During the embargo period, you may request access to the item by clicking the link to the restricted file(s) and completing the request form. If we have contact information for a Cornell author, we will contact the author and request permission to provide access. If we do not have contact information for a Cornell author, or the author denies or does not respond to our inquiry, we will not be able to provide access. For more information, review our policies for restricted content.
The prevalence of cardiovascular disease increases with age, driven by processes of inflammation, oxidative stress, and mitochondrial dysfunction. Delaying the cascade caused by these risk factors will be essential to reducing cardiovascular morbidity and mortality in our aging population. Sirtuins are nicotinamide adenine dinucleotide-dependent deacetylase enzymes involved in metabolic regulation that show promise in attenuating these disease processes and increasing longevity. This review will examine the role of sirtuins at the cellular level in relation to cardiovascular health and discuss their potential as novel therapeutic targets for atherosclerosis, heart failure, and metabolic syndrome.